Home › Axovant Sciences - The Late Clinical Stage Biotech With Huge IPO Potential
 

Keywords :   


Axovant Sciences - The Late Clinical Stage Biotech With Huge IPO Potential

2015-06-09 21:00:38| Biotech - Topix.net

Axovant Sciences is a late-stage clinical trial biotech preparing for its initial public offering the week of June 8. The company's lead drug candidate is an Alzheimer's treatment currently in Phase 3 trials. Axovant acquired the intellectual property and rights from GlaxoSmithKline .

Tags: potential late stage huge

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06The big problem facing whoever wins the election
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Public Advisory Number 5A
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Atlantic Tropical Weather Outlook
30.06Eastern North Pacific Tropical Weather Outlook
29.06Hurricane Beryl Graphics
29.06Hurricane Beryl Forecast Discussion Number 5
More »